ATAD3C
ATPase family AAA domain-containing protein 3C
Also known as: ATD3C_HUMAN, FLJ34599
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T2N8
- Gene
- ATAD3C
- Ensembl
- ENSG00000215915
- Chromosome
- 1
- Canonical length
- 411 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Predicted to enable ATP binding activity and ATP hydrolysis activity. Predicted to be involved in mitochondrion organization. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
411 residues, UniProt reviewed canonical sequence.
>Q5T2N8|ATAD3C
1 MSKDALNLAQ MQEQTLQLEQ QSKLKQLVNE DLRKQEESVQ KHHQTFLESI RAAGTLFGEG
61 FRAFVTDRDK VTATVAGLTL LAVGVYSAKN ATAVTGRYIE ARLGKPSLVR ETSRITVLEA
121 LRHPIQQVSR RLLSRPQDVL EGVVLSPSLE ARVRDIAIMT RNIKKNRGLY RHILLYGPPG
181 TGKTLFAKKL ALHSGMDYAI MTGGDVAPMG REGVTAMHKL FDWANTSRRG LLLFVDEADA
241 FLRKRATEKI SEDLRATLNA FLYRTGQHSN KFMLILASCH PEQFDWAINA CIDVMVHFDL
301 PGQEERARLV RMYLNEYVLK PATEGKRRLK LAQFDYGRKC LEIARLTEGM SCRKIAQLAV
361 SWQATAYASK DGVLTEAMMD ACVQDFVQQH QQMMRWLKGE RPGPEDEQPS SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATAD3C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 5.3 nTPM
Expression across tissuesHPA
Tissue
- liver: 5.3 nTPM
- kidney: 4.4 nTPM
- pancreas: 4.4 nTPM
- spinal cord: 4.2 nTPM
- prostate: 3.9 nTPM
- thyroid gland: 3.8 nTPM
Single-cell type
- oocytes: 60 nCPM
- epididymal efferent duct absorptive cells: 33 nCPM
- alveolar cells type 1: 28 nCPM
- alveolar cells type 2: 28 nCPM
- plasma cells: 25 nCPM
- epididymal clear cells: 23 nCPM
Immune cell
- MAIT T-cell: 1.2 nTPM
- basophil: 0.7 nTPM
- T-reg: 0.6 nTPM
- memory B-cell: 0.5 nTPM
- naive CD4 T-cell: 0.5 nTPM
- NK-cell: 0.5 nTPM
Brain region
- white matter: 14 nTPM
- cerebral cortex: 9 nTPM
- medulla oblongata: 7.9 nTPM
- pons: 7.2 nTPM
- basal ganglia: 7 nTPM
- hypothalamus: 6.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.82
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATAD3C as an antibody target. Whether an autoantibody or antibody against ATAD3C could matter depends on whether native ATAD3C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATAD3C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATAD3C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...